Insights from
the Acutis Experts
Perspectives and updates from our scientific team
on emerging trends in diagnostics, infectious disease,
and clinical toxicology.
- Acutis
- |
Fentanyl Testing in 2026: Why Norfentanyl Matters More Than Cutoff Alone
When evaluating a fentanyl urine drug test, it is easy to focus on one number: ...
- Acutis
- |
Sublocade and Buprenorphine Testing: Why Oral Fluid May Matter After the Last Injection
Case: A 35 years old male with a history of opioid abuse was on Sublocade ...
- Acutis
- |
Why Iowa’s Prior Authorization Reform Matters for Behavioral Health and Recovery
Iowa House File 2635 (HF2635) is a healthcare reform bill that was passed by the ...
- Acutis
- |
Acutis Expands Diagnostic Services into Kentucky, Strengthening Payer Collaboration Through Value-Driven Care
Kentucky, USA – 26 March 2026 — New York-based Acutis Diagnostics, a leader in advanced ...
- Acutis
- |
Provider Concern: accuracy and dependability of diagnostic lab testing
Let our team ease your troubles when it comes to urinary tract infection testing with ...
- Acutis
- |
Mail-backs for Opioid Analgesics Dispensed in Outpatient Settings | FDA
Opioid Use Disorder (OUD) It is one of the biggest public health threats of this ...
